Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 10, 2014 - Issue 10
Submit an article Journal homepage
516
Views
13
CrossRef citations to date
0
Altmetric
Drug Evaluations

Pharmacokinetic/pharmacodynamic evaluation of rasagiline mesylate for Parkinson’s disease

Thomas MüllerSt. Joseph Hospital Berlin-Weißensee, Department of Neurology, Gartenstr. 1, 13088 Berlin, Germany+49 30 92790223; +49 30 92790703; [email protected]; [email protected]
, MD
Pages 1423-1432 | Published online: 06 Sep 2014

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Thomas Müller & Jan-Dominique Möhr. (2019) Pharmacokinetics of monoamine oxidase B inhibitors in Parkinson’s disease: current status. Expert Opinion on Drug Metabolism & Toxicology 15:5, pages 429-435.
Read now
Thomas Müller. (2018) Safinamide: an add-on treatment for managing Parkinson’s disease. Clinical Pharmacology: Advances and Applications 10, pages 31-41.
Read now
Ravindrababu Pingili, Sridhar Vemulapalli, Surya Sandeep Mullapudi, Siddhartha Nuthakki, Sivaprasad Pendyala & Naveenbabu Kilaru. (2016) Pharmacokinetic interaction study between flavanones (hesperetin, naringenin) and rasagiline mesylate in wistar rats. Drug Development and Industrial Pharmacy 42:7, pages 1110-1117.
Read now

Articles from other publishers (10)

Zhongxiong Fan, Hao Jin, Xiaofeng Tan, Ying Li, Dao Shi, Qiuli Wang, Jiahao Meng, Wenjun Li, Caixia Chen, Lu Peng, Zhenqing Hou, Jingwen Li, Xin Jin & Lichao Yang. (2023) ROS-responsive hierarchical targeting vehicle-free nanodrugs for three-pronged Parkinson’s disease therapy. Chemical Engineering Journal 466, pages 143245.
Crossref
Hala N. ElShagea, Rana R. Makar, Alaa H. Salama, Nermeen A. Elkasabgy & Emad B. Basalious. (2023) Investigating the Targeting Power to Brain Tissues of Intranasal Rasagiline Mesylate-Loaded Transferosomal In Situ Gel for Efficient Treatment of Parkinson’s Disease. Pharmaceutics 15:2, pages 533.
Crossref
Miguel Reina, Eduardo Gabriel Guzmán‐López & Annia Galano. (2022) Computational design of rasagiline derivatives: Searching for enhanced antioxidant capability. International Journal of Quantum Chemistry 123:2.
Crossref
Thuỳ Linh Phạm, Chan Noh, Chiranjivi Neupane, Ramesh Sharma, Hyun Jin Shin, Ki Duk Park, C. Justin Lee, Hyun-Woo Kim, So Yeong Lee & Jin Bong Park. (2022) MAO-B Inhibitor, KDS2010, Alleviates Spinal Nerve Ligation-induced Neuropathic Pain in Rats Through Competitively Blocking the BDNF/TrkB/NR2B Signaling. The Journal of Pain 23:12, pages 2092-2109.
Crossref
Thomas Müller. 2020. Diagnosis and Management in Parkinson's Disease. Diagnosis and Management in Parkinson's Disease 477 490 .
N. Kanwar, R. Bhandari, A. Kuhad & V. R. Sinha. (2019) Polycaprolactone-based neurotherapeutic delivery of rasagiline targeting behavioral and biochemical deficits in Parkinson’s disease. Drug Delivery and Translational Research 9:5, pages 891-905.
Crossref
Peter Riederer & Thomas Müller. (2018) Monoamine oxidase-B inhibitors in the treatment of Parkinson’s disease: clinical–pharmacological aspects. Journal of Neural Transmission 125:11, pages 1751-1757.
Crossref
Thomas MüllerPeter RiedererEdna Grünblatt. (2017) Determination of Monoamine Oxidase A and B Activity in Long-Term Treated Patients With Parkinson Disease. Clinical Neuropharmacology 40:5, pages 208-211.
Crossref
Xia Chen, Qian Zhao, Ji Jiang, Jian Liu & Pei Hu. (2016) Pharmacokinetics of Rasagiline in Healthy Adult Chinese Volunteers with Various Genotypes: A Single-Center, Open-Label, Multiple-Dose Study. Clinical Drug Investigation 36:5, pages 369-376.
Crossref
Thomas Müller. (2015) Catechol-O-Methyltransferase Inhibitors in Parkinson’s Disease. Drugs 75:2, pages 157-174.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.